Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

United Therapeutics (UTHR)

NASDAQ:UTHR

UTHR

United Therapeutics

RESEARCH TOOLSreports

United Therapeutics (UTHR) Ratios

Compare

681 Followers

United Therapeutics Ratios

UTHR's free cash flow for Q3 2025 was $0.87. For the 2025 fiscal year, UTHR's free cash flow was decreased by $ and operating cash flow was $0.55. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	6.40	4.41	9.85	7.61	6.70
Quick Ratio	6.07	4.28	9.55	7.30	6.44
Cash Ratio	2.45	1.50	2.80	2.93	2.28
Solvency Ratio	1.71	0.88	0.62	0.43	0.46
Operating Cash Flow Ratio	2.85	1.22	2.34	1.96	2.34
Short-Term Operating Cash Flow Coverage	0.00	2.44	0.00	0.00	0.00
Net Current Asset Value	$ 2.73B	$ 2.37B	$ 2.13B	$ 1.11B	$ 947.40M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.10	0.13	0.15	0.17
Debt-to-Equity Ratio	0.00	0.12	0.17	0.20	0.24
Debt-to-Capital Ratio	0.00	0.10	0.14	0.17	0.19
Long-Term Debt-to-Capital Ratio	0.00	0.05	0.14	0.17	0.19
Financial Leverage Ratio	1.12	1.20	1.26	1.31	1.36
Debt Service Coverage Ratio	53.99	2.39	25.22	33.26	22.22
Interest Coverage Ratio	61.46	19.98	30.24	29.89	25.26
Debt to Market Cap	0.00	0.07	0.06	0.08	0.12
Interest Debt Per Share	0.55	16.22	18.29	18.23	18.63
Net Debt to EBITDA	-0.79	-0.37	-0.15	-0.13	0.09
Profitability Margins
Gross Profit Margin	88.59%	88.94%	92.42%	92.73%	92.71%
EBIT Margin	53.65%	57.30%	51.08%	40.75%	40.21%
EBITDA Margin	54.55%	59.58%	53.73%	43.71%	43.57%
Operating Profit Margin	47.74%	50.91%	50.60%	32.98%	40.02%
Pretax Profit Margin	53.27%	54.75%	49.09%	35.24%	43.07%
Net Profit Margin	40.65%	42.31%	37.56%	28.23%	34.71%
Continuous Operations Profit Margin	40.65%	42.31%	37.56%	28.23%	34.71%
Net Income Per EBT	76.31%	77.28%	76.51%	80.11%	80.58%
EBT Per EBIT	111.58%	107.54%	97.03%	106.84%	107.63%
Return on Assets (ROA)	17.30%	13.74%	12.03%	9.20%	11.15%
Return on Equity (ROE)	18.83%	16.46%	15.16%	12.02%	15.16%
Return on Capital Employed (ROCE)	21.95%	18.62%	17.18%	11.43%	13.83%
Return on Invested Capital (ROIC)	16.75%	13.54%	13.15%	9.16%	11.14%
Return on Tangible Assets	17.58%	13.96%	12.12%	9.28%	11.55%
Earnings Yield	6.29%	9.57%	5.75%	4.90%	7.67%
Efficiency Ratios
Receivables Turnover	10.51	8.35	8.79	8.48	9.42
Payables Turnover	0.76	45.98	35.78	32.24	26.37
Inventory Turnover	2.02	2.30	1.44	1.31	1.25
Fixed Asset Turnover	2.01	2.23	2.25	2.16	2.03
Asset Turnover	0.43	0.32	0.32	0.33	0.32
Working Capital Turnover Ratio	1.00	0.80	0.77	0.87	0.91
Cash Conversion Cycle	-263.38	194.27	285.13	311.19	316.96
Days of Sales Outstanding	34.73	43.74	41.55	43.03	38.73
Days of Inventory Outstanding	180.51	158.47	253.78	279.49	292.07
Days of Payables Outstanding	478.62	7.94	10.20	11.32	13.84
Operating Cycle	215.24	202.21	295.33	322.51	330.80
Cash Flow Ratios
Operating Cash Flow Per Share	35.53	20.90	17.64	13.32	17.10
Free Cash Flow Per Share	25.61	15.97	14.59	10.63	15.76
CapEx Per Share	9.92	4.92	3.05	2.69	1.34
Free Cash Flow to Operating Cash Flow	0.72	0.76	0.83	0.80	0.92
Dividend Paid and CapEx Coverage Ratio	3.58	4.24	5.78	4.95	12.74
Capital Expenditure Coverage Ratio	3.58	4.24	5.78	4.95	12.74
Operating Cash Flow Coverage Ratio	0.00	1.40	1.00	0.75	0.94
Operating Cash Flow to Sales Ratio	0.50	0.42	0.41	0.35	0.51
Free Cash Flow Yield	5.44%	7.26%	5.25%	4.92%	10.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	15.84	10.45	17.40	20.39	13.03
Price-to-Sales (P/S) Ratio	6.57	4.42	6.53	5.76	4.52
Price-to-Book (P/B) Ratio	3.06	1.72	2.64	2.45	1.98
Price-to-Free Cash Flow (P/FCF) Ratio	18.32	13.77	19.06	20.32	9.63
Price-to-Operating Cash Flow Ratio	12.95	10.52	15.77	16.22	8.88
Price-to-Earnings Growth (PEG) Ratio	5.49	0.33	0.34	-2.26	-0.02
Price-to-Fair Value	3.06	1.72	2.64	2.45	1.98
Enterprise Value Multiple	11.26	7.05	12.01	13.04	10.48
Enterprise Value	19.28B	9.78B	12.49B	9.61B	6.77B
EV to EBITDA	11.30	7.05	12.01	13.04	10.48
EV to Sales	6.16	4.20	6.45	5.70	4.56
EV to Free Cash Flow	17.18	13.09	18.82	20.12	9.72
EV to Operating Cash Flow	12.39	10.00	15.57	16.06	8.96
Tangible Book Value Per Share	147.80	125.44	104.44	87.18	73.24
Shareholders’ Equity Per Share	150.46	127.88	105.42	88.17	76.81
Tax and Other Ratios
Effective Tax Rate	0.24	0.23	0.23	0.20	0.19
Revenue Per Share	71.42	49.73	42.56	37.54	33.56
Net Income Per Share	29.03	21.04	15.98	10.60	11.65
Tax Burden	0.76	0.77	0.77	0.80	0.81
Interest Burden	0.99	0.96	0.96	0.86	1.07
Research & Development to Revenue	0.17	0.18	0.17	0.32	0.24
SG&A to Revenue	0.14	0.17	0.21	0.24	0.25
Stock-Based Compensation to Revenue	0.04	0.02	0.06	0.08	0.11
Income Quality	1.22	0.99	1.10	1.26	1.47

Currency in USD